Monitor for additional payer agreements and test volume growth to gauge revenue trajectory. The expansion to 81M covered lives is positive but gradual; next milestone is the 150M target for 2026.
Price Chart
Executive Summary
Plus Therapeutics subsidiary CNSide Diagnostics secured a new payer coverage agreement with Blue Shield of California, expanding total covered lives from 75M to 81M. This incremental step supports reimbursement and adoption of the CNSide CSF assay for leptomeningeal metastases detection but does not include revenue or financial guidance.
Key Facts
- New payer coverage agreement with Blue Shield of California, effective April 2026
- Total covered lives increased from approximately 75 million to 81 million
- Company targets 150 million covered lives in 2026
- Over 11,000 CNSide tests performed at 120+ U.S. cancer institutions since 2020
- CNSide assay demonstrates 92% sensitivity and 95% specificity
Financial Impact
No financial terms disclosed; incremental reimbursement expansion for a laboratory-developed test
Risk Factors
- Payer adoption may be slower than expected; 150M target uncertain
- Competition from alternative diagnostic methods (e.g., liquid biopsy) could limit market share
- CNSide is a single-assay product; revenue concentration risk
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3282472 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Jul 21, 2026 14w ago | Press Release | $3.92 | awaiting T+20 | — | — |
Jun 30, 2026 17w ago | Press Release | $4.37 $3.73 | ▼ −14.65% | ▼ −13.62% | — |
Jun 8, 2026 20w ago | EFFECT | $5.53 $4.05 | ▲ +26.76% | ▲ +28.39% | — |
Jun 5, 2026 20w ago | S-3/A | $5.41 $4.05 | ▼ −25.14% | ▼ −27.00% | — |
May 19, 2026 23w ago | Press Release | $5.83 $4.31 | ▼ −26.07% | ▼ −27.06% | — |
May 15, 2026 23w ago | Press Release | $5.84 $4.57 | ▲ +21.75% | ▲ +23.33% | — |
May 8, 2026 24w ago | Press Release | $6.12 $5.41 | ▼ −11.60% | ▼ −11.62% | — |
Apr 28, 2026 26w ago | Press Release | $5.95 $6.60 | ▲ +10.92% | ▲ +5.46% | — |
Apr 21, 2026 27w ago | 8-K | $7.14 $5.84 | ▼ −18.21% | ▼ −23.12% | — |
Apr 9, 2026 28w ago | 8-K | $3.92 $6.00 | ▲ +53.06% | ▲ +45.49% | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers